These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36920504)

  • 1. Analytical Performance of the New Siemens Affinity Chrome-Mediated Immunoassay Everolimus Assay and Its Interchangeability With the Thermo Quantitative Microsphere System for Routine Therapeutic Drug Monitoring of Patients After Solid Organ Transplantation.
    Ialongo C; Sapio M; Angeloni A
    Ther Drug Monit; 2023 Apr; 45(2):217-222. PubMed ID: 36920504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the interchangeability between the new fully-automated affinity chrome-mediated immunoassay (ACMIA) and the Quantitative Microsphere System (QMS) with a CE-IVD-certified LC-MS/MS assay for therapeutic drug monitoring of everolimus after solid organ transplantation.
    Ialongo C; D'alessandro A; Sapio M; Angeloni A; Porzio O
    Clin Chem Lab Med; 2023 Jan; 61(2):245-250. PubMed ID: 36330751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical performance of QMS everolimus assay on ortho Vitros 5,1 FS fusion analyzer: measuring everolimus trough levels for solid organ transplant recipients.
    Shu I; Wright AM; Chandler WL; Bernard DW; Wang P
    Ther Drug Monit; 2014 Apr; 36(2):264-8. PubMed ID: 24232125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of QMS everolimus assay using Indiko analyzer: comparison with an ultra-performance liquid chromatography-tandem mass spectrometry method.
    Buthiau D; Bargnoux AS; Badiou S; Sutra T; Dupuy AM; Pageaux GP; Mourad G; Cristol JP
    Ther Drug Monit; 2015 Apr; 37(2):275-8. PubMed ID: 25254414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of everolimus QMS immunoassay on Architect ci4100 and liquid chromatography/mass spectrometry: lack of agreement in organ-transplanted patients.
    Hoffer E; Kurnik D; Efrati E; Scherb I; Karasik M; Ring G; Bentur Y
    Ther Drug Monit; 2015 Apr; 37(2):214-9. PubMed ID: 25162218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Drug Monitoring of Everolimus: Comparability of Concentrations Determined by 2 Immunoassays and a Liquid Chromatography Tandem Mass Spectrometry Method.
    Shipkova M; Rapp S; Rigo-Bonnin R; Wieland E; Peter A
    Ther Drug Monit; 2017 Apr; 39(2):102-108. PubMed ID: 28125504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of QMS everolimus assay using Hitachi 917 Analyzer: comparison with liquid chromatography/mass spectrometry.
    Dasgupta A; Davis B; Chow L
    Ther Drug Monit; 2011 Apr; 33(2):149-54. PubMed ID: 21266941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Performance of Laboratory-Developed Liquid Chromatography-Tandem Mass Spectrometry Tests and a Food and Drug Administration-Approved Immunoassay for the Therapeutic Drug Monitoring of Everolimus.
    Schniedewind B; Meyer EJ; Christians U
    Ther Drug Monit; 2020 Jun; 42(3):421-426. PubMed ID: 32427781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
    Tempestilli M; Di Stasio E; Basile MR; Elisei F; Antonini M; Ettorre GM; Iappelli M; Pucillo LP
    Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of Interchangeability Between 3 Different Methods for Quantification of Everolimus in Blood: ACMIA, LTIA, and UHPLC-MS/MS.
    Miyagi C; Tanaka R; Shiraiwa K; Tatsuta R; Itoh H
    Ther Drug Monit; 2024 Jul; ():. PubMed ID: 39083351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the everolimus concentrations measured in whole blood with everolimus QMS or sirolimus CMIA.
    Capone D; Cataldi M; Guida B; Mosca T; Tarantino G
    Scand J Clin Lab Invest; 2018 Jul; 78(4):275-280. PubMed ID: 29575933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the New Siemens Tacrolimus Assay on the Dimension EXL Integrated Chemistry System Analyzer: Comparison With an Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method.
    Bargnoux AS; Sutra T; Badiou S; Kuster N; Dupuy AM; Mourad G; Pageaux GP; Le Quintrec M; Cristol JP
    Ther Drug Monit; 2016 Dec; 38(6):808-812. PubMed ID: 27494947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter Evaluation of a New Electrochemiluminescence Immunoassay for Everolimus Concentrations in Whole Blood.
    Verstraete AG; Rigo-Bonnin R; Wallemacq P; Vogeser M; Schuetzenmeister A; Schmiedel C; Shipkova M
    Ther Drug Monit; 2018 Feb; 40(1):59-68. PubMed ID: 29210975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
    Bazin C; Guinedor A; Barau C; Gozalo C; Grimbert P; Duvoux C; Furlan V; Massias L; Hulin A
    J Pharm Biomed Anal; 2010 Dec; 53(4):997-1002. PubMed ID: 20674215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus Monitoring in Liver Transplant Recipients, Posttransplant Cholestasis: A Comparative Between 2 Commercial Immunoassays and a Liquid Chromatography-Tandem Mass Spectrometry Method.
    Parant F; Delignette MC; Charpiat B; Lacaille L; Lebosse F; Monneret G; Mohkam K; Mabrut JY; Aubrun F; Heyer L; Antonini T
    Ther Drug Monit; 2024 Aug; 46(4):446-455. PubMed ID: 38648663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry for Cyclosporine Analysis in Human Whole Blood and Comparison With an Antibody-Conjugated Magnetic Immunoassay.
    Mei S; Wang J; Chen D; Zhu L; Zhao M; Hu X; Yang L; Zhao Z
    Ther Drug Monit; 2018 Feb; 40(1):69-75. PubMed ID: 29206806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.
    Johnson-Davis KL; De S; Jimenez E; McMillin GA; De BK
    Ther Drug Monit; 2011 Aug; 33(4):453-9. PubMed ID: 21743377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of a dried blood spot assay for sirolimus and everolimus in transplant patients.
    Veenhof H; Koster RA; Alffenaar JC; van den Berg AP; de Groot MR; Verschuuren EAM; Berger SP; Bakker SJL; Touw DJ
    Clin Chem Lab Med; 2019 Nov; 57(12):1854-1862. PubMed ID: 30939110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy evaluation of automated electrochemiluminescence immunoassay for everolimus and sirolimus compared to liquid chromatography-tandem mass spectrometry.
    Lee EJ; Kim HK; Ahn S; Lee W; Kim HS; Chun S; Min WK
    J Clin Lab Anal; 2019 Sep; 33(7):e22941. PubMed ID: 31197901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a precise quantitative method for monitoring sirolimus in whole blood using LC/ESI-MS/MS.
    Shigeta K; Kikuchi M; Tanaka M; Takasaki S; Oishi H; Sado T; Matsuda Y; Noda M; Okada Y; Mano N; Yamaguchi H
    Biomed Chromatogr; 2020 Aug; 34(8):e4853. PubMed ID: 32302012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.